To cite this paper use one of the standards below:
Schistosomiasis is one of the most important parasitic infections among neglected diseases, since affects over than 250 million people, its being reported in 78 countries accordingly to WHO, causing an enormous impact on public health and economics. Since praziquantel currently is the only drug available for schistosomiasis treatment, there is an urgent need to identify new anthelmintic agents. Its effectiveness key is against adult worms and immature stages, but do not responses in pre-patent period treatments, that may result in recurrence. It is known that praziquantel MoA increases the permeability of helminthic cell membranes to Ca2+, causing paralysis, resulting in portal-hepatic worm dislodgement and death. Piplartine (fig. 1), also known as piperlongumine, is biologically active amide alkaloid from peppers was also detected in the roots of Piper tuberculatum. In this present work, in vivo anthelminthic properties of piplartine was evaluated using a mouse model schistosomiasis, infected with Schistosoma mansoni in either adult (patent infection) and juvenile (pre-patent infection) stage forms. A single dose of piplartine using (100, 200 or 400 mg/kg) or daily for five consecutive days (100 mg/kg/day) administered orally to mice infected with schistosomes resulted in a reduction in worm burden and egg production. Treatment with the highest piplartine dose (400 mg/kg) caused a significant reduction in a total worm burden of 60.4% (P < 0.001), especially in mice harboring adult parasites. S. mansoni egg production, a process responsible for granulomatous inflammation pathology in schistosomiasis, was also significantly inhibited by piplartine. In addition, studies using scanning electron microscopy revealed substantial tegumental alterations in parasites harvested from mice liver. Since piplartine has well-characterized mechanisms of toxicity, easily available, and good cost-effectiveness, our results indicate that this bioactive molecule derived from medicinal plants could be a potential scaffold treatment for schistosomiasis, but its mode of action on specific targets, remains unknown.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper